Clinical

Articles

Marinus Pharmaceuticals’ positive allosteric GABAA receptor modulator ganaxolone was associated with significant median reductions in 28-day major motor seizure frequency compared to placebo.

Ganaxolone Meets Primary End Point in CDKL5 Deficiency Disorder Study

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending September 18, 2020.

NeurologyLive Friday 5 — September 18, 2020

In part 2 of this interview, Leah Croll, MD, a neurology resident on the front lines of the COVID-19 pandemic, describes how her resident program experience was impacted by the pandemic. 

Neurology Residency Training During a Pandemic

Day of Dravet, a 1-day virtual event on Saturday, October 17th will give attendees an opportunity to meet industry representatives and ask questions. 

Dravet Syndrome Foundation to Host Virtual Workshop

Videos

Sucheta M. Joshi, MD, MS, and Nicholas Beimer, MD, discuss their experience with EpiTRAQ and the role it can play in optimizing the epilepsy care transition.

Optimizing Care Transition for Adolescents With Epilepsy

The 7th International LGS Foundation Family Conference features interactive Q&A's, breakout sessions, interactive games, and access to the after party with LGS caregivers. 

Epilepsy

New content coming soon, please check back later.